Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
No human trial has measured outcomes for cagrilintide + tirzepatide as a stack
References Bhm, M
These genetic markers may help provide context for medication selection and support a more informed conversation between patient and provider about which treatment class aligns with individual predispositions
10.3390/polym14132700 80 RagusaA.SvelatoA.SantacroceC.CatalanoP.NotarstefanoV.CarnevaliO.et al (2021)
"The biggest thing I've seen in my practice is that patients who are obese can take these medications and have dramatic reductions in their weight, while doing it in a healthy fashion with a tolerable treatment," Dr
In the future, the researchers also want to take people's pre-GLP weights into account and find a comparison group with comparable baseline BMIs, Maya said
